- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03062969
The Transition From Blastomere to Trophectoderm Biopsy: Comparing Two PGS Strategies
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The investigators have recently introduced this new approach and a frozen-thawed policy of euploid blastocysts is routinely performed.
This is a single centre retrospective study in patients undergoing a PGS cycle. The aim of the study is to assess the results obtained in a PGS programme after the implementation of a new biopsy timing and transfer policy. Results obtained in PGS cycles with blastocyst biopsy and frozen-thawed embryo transfer were analysed in comparison to cycles with cleavage stage biopsy and fresh blastocyst transfer.
Study Type
Enrollment (Actual)
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Own gametes
- PGS for: advanced maternal age, repeated implantation failure, recurrent miscarriages, severe male factor, and previous affected pregnancies
Exclusion Criteria:
- PGS cycles with gamete donation
- Altered karyotypes
- Combined Preimplantation genetic diagnosis (PGD)+PGS cycles
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Cleavage stage biopsy group
Patients undergoing a PGS cycle with single blastomere biopsy on day 3 and analysis using comparative genomic hybridation bacterial artificial chromosome (BAC) arrays (aCGH) If euploid blastocysts were available, patients underwent fresh blastocyst transfer on day 5.
|
|
Trophectoderm biopsy group
Patients undergoing a PGS cycle with blastocyst biopsy on day 5-7 and analysis using comparative genomic hybridation bacterial artificial chromosome (BAC) arrays (aCGH).
If euploid blastocysts were available, patients underwent frozen-thawed blastocyst transfer.
|
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Ongoing clinical pregnancy rate
Time Frame: 20 weeks after embryo transfer
|
Clinical pregnancy confirmed by ultrasound
|
20 weeks after embryo transfer
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Miscarriage Rate
Time Frame: Until 20 weeks after embryo transfer
|
Until 20 weeks after embryo transfer
|
|
Implantation Rate
Time Frame: 6 weeks after embryo transfer
|
Embryos implanted confirmed by ultrasound
|
6 weeks after embryo transfer
|
Number of available euploid blastocysts per cycle
Time Frame: Up to 15 days after embryo biopsy
|
Transferable or vitrified euploid blastocysts
|
Up to 15 days after embryo biopsy
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- FDS-PGS-01
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Infertility
-
Assuta Hospital SystemsMaccabi Healthcare Services, IsraelCompletedInfertility, Female Infertility, Male InfertilityIsrael
-
Radboud University Medical CenterZonMw: The Netherlands Organisation for Health Research and DevelopmentCompletedPregnancy | Male Infertility | Female InfertilityNetherlands
-
Sapientiae InstituteTerminated
-
Esraa Gamal AhmedAin Shams Maternity HospitalUnknownUnexplained Female Infertility
-
King's College LondonNot yet recruitingInfertility | Infertility, Female | Infertility Unexplained | Infertility of Tubal Origin
-
Gazi UniversityCompletedMale Infertility | Unexplained Infertility
-
University of WashingtonEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedMale Infertility, AzoospermiaUnited States
-
Pacific Fertility CenterTerminatedPrimary Female Infertility | Secondary Female Infertility
-
Wake Forest University Health SciencesWithdrawnUterine Diseases | Endometriosis | Infertility Unexplained | Endometrial Diseases | Infertility; Female, NonimplantationUnited States
-
Istanbul University - Cerrahpasa (IUC)RecruitingInfertility | Sexual Dysfunction | Infertility, Male | Nurse's Role | Sexuality | Infertility; FemaleTurkey
Clinical Trials on Cleavage stage biopsy group
-
Institut Universitari DexeusTerminatedInfertility, Female | Embryo Transfer | Oocyte DonationSpain
-
Ganin Fertility CenterUnknownInfertility, Female | Poor Response to Ovulation InductionEgypt
-
The First Affiliated Hospital with Nanjing Medical...The First Affiliated Hospital of Anhui Medical University; RenJi Hospital; The... and other collaboratorsCompleted
-
Women's Hospital School Of Medicine Zhejiang UniversityORGANON (SHANGHAI) PHARMACEUTICAL TECHNOLOGY CO., LTD.Not yet recruiting
-
Université Libre de BruxellesAristotle University Of ThessalonikiUnknown
-
National Yang Ming UniversityRecruiting
-
Gennaro SardellaUnknownNon ST Segment Elevation MI and Unstable AnginaItaly
-
Centre Hospitalier Universitaire de NiceRecruiting
-
Taihe HospitalCompleted
-
Shirley Ryan AbilityLabRecruitingSpinal Cord InjuriesUnited States